Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
45 participants
OBSERVATIONAL
2010-01-31
2011-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Material and Method: Forty-five patients, ASA (American Society of Anesthesiologists) I-II, score between 18-50 years with planned laparoscopic cholecystectomy under general anesthesia were included in the study. Patients were divided into 3 groups as total intravenous anesthesia (TIVA) (group T n: 15), sevoflurane (group S n: 15) and desflurane (group D n: 15). Propofol 2 mg/kg IV, fentanyl 1 mcg/kg IV, vecuronium 0.1 mg/kg IV given to all groups for anesthesia induction. For maintenance of anesthesia group S were ventilated with 2% sevoflurane, 50% air and 50% O2 mix at 6 L/min flow. Group D were given 6% desflurane 50% air and 50% O2 mix at 6 L/min flow. Group T were given propofol infusions of 12 mg/kg/hr for the first 10 minutes, 9 mg/kg/hr for the second 10 minutes and 6 mg/kg/hr after that. Patients were ventilated with 50% air and 50% O2 mix at 6 L/min flow. Before induction and after the operation venous blood samples were taken to evaluate the levels of glutathion peroxidase, total oxidants and antioxidants.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of the Anesthetic Effect on the Activity of Immune Cell in Patient With Breast Cancer
NCT02567929
Anesthetic Effect on Immune Cell in Patients With Cancer
NCT02758249
Effect of Type of General Anesthesia Maintenance on Exhaled Nitric Oxide and Eosinophil Blood Count
NCT02065635
Oxidative Stress Related to 2 Different Oxygen Concentrations During General Anesthesia. Clinical Trial.
NCT02619214
The Effect of Propofol Infusion on Total Antioxidant Status During Tourniquet-Induced Ischemia-Reperfusion Injury
NCT01638624
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TIVA (group T n: 15)
Group T were given propofol infusions of 12 mg/kg/hr for the first 10 minutes, 9 mg/kg/hr for the second 10 minutes and 6 mg/kg/hr after that. Patients were ventilated with 50% air and 50% O2 mix at 6 L/min flow.
No interventions assigned to this group
Sevoflurane (group S n: 15)
Group S were ventilated with 2% sevoflurane, 50% air and 50% O2 mix at 6 L/min flow.
No interventions assigned to this group
Desflurane (group D n: 15)
Group D cases were given 6% desflurane 50% air and 50% O2 mix at 6 L/min flow.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Between 18-50 years
* Planned laparoscopic cholecystectomy under general anesthetic
Exclusion Criteria
* blood transfusion in the previous 2 weeks
* signs of infection and inflammation
* history of preoperative medication use
* anemia
* hemorrhage requiring transfusion during the operation were excluded from the study.
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Duzce University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
yavuz demiraran
Professor Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
yavuz demiraran, MD prof
Role: PRINCIPAL_INVESTIGATOR
duzce university medical faculty
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Duzce Univercity Medical Fauculty
Düzce, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MESUT-81
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.